Works matching IS 00099104 AND DT 2019 AND VI 195 AND IP 3

Results: 13

Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 334, doi. 10.1111/cei.13255
By:
- Pawłowska, A.;
- Suszczyk, D.;
- Okła, K.;
- Barczyński, B.;
- Kotarski, J.;
- Wertel, I.
Publication type:
Article
Secretory immunoglobulin A induces human lung fibroblasts to produce inflammatory cytokines and undergo activation.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 287, doi. 10.1111/cei.13253
By:
- Arakawa, S.;
- Suzukawa, M.;
- Watanabe, K.;
- Kobayashi, K.;
- Matsui, H.;
- Nagai, H.;
- Nagase, T.;
- Ohta, K.
Publication type:
Article
Contribution of FoxP3+ Tfr cells to overall human blood CXCR5+ T cells.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 302, doi. 10.1111/cei.13245
By:
- Fonseca, V. R.;
- Graca, L.
Publication type:
Article
FoxP3+CXCR5+CD4+ T cell frequencies are increased in peripheral blood of patients with primary Sjögren's syndrome.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 305, doi. 10.1111/cei.13244
By:
- Ivanchenko, M.;
- Aqrawi, L.A.;
- Björk, A.;
- Wahren‐Herlenius, M.;
- Chemin, K.
Publication type:
Article
Behçet's syndrome as a tool to dissect the mechanisms of thrombo‐inflammation: clinical and pathogenetic aspects.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 322, doi. 10.1111/cei.13243
By:
- Becatti, M.;
- Emmi, G.;
- Bettiol, A.;
- Silvestri, E.;
- Di Scala, G.;
- Taddei, N.;
- Prisco, D.;
- Fiorillo, C.
Publication type:
Article
The immunopathogenesis of fibrosis in systemic sclerosis.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 310, doi. 10.1111/cei.13238
By:
- Brown, M.;
- O'Reilly, S.
Publication type:
Article
Colonization of preterm gnotobiotic piglets with probiotic Lactobacillus rhamnosus GG and its interference with Salmonella Typhimurium.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 381, doi. 10.1111/cei.13236
By:
- Splichalova, A.;
- Jenistova, V.;
- Splichalova, Z.;
- Splichal, I.
Publication type:
Article
Autoantibodies to killer cell immunoglobulin‐like receptor 3DL1 in patients with systemic lupus erythematosus.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 358, doi. 10.1111/cei.13235
By:
- Doi, A.;
- Kano, S.;
- Asano, M.;
- Takahashi, Y.;
- Mimori, T.;
- Mimori, A.;
- Kaneko, H.
Publication type:
Article
CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 345, doi. 10.1111/cei.13233
By:
- Lyu, M.;
- Li, Y.;
- Hao, Y.;
- Lyu, C.;
- Huang, Y.;
- Sun, B.;
- Li, H.;
- Xue, F.;
- Liu, X.;
- Yang, R.
Publication type:
Article
Monocytes show immunoregulatory capacity on CD4+ T cells in a human in‐vitro model of extracorporeal photopheresis.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 369, doi. 10.1111/cei.13232
By:
- Wiese, F.;
- Reinhardt‐Heller, K.;
- Volz, M.;
- Gille, C.;
- Köstlin, N.;
- Billing, H.;
- Handgretinger, R.;
- Holzer, U.
Publication type:
Article
21‐hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 364, doi. 10.1111/cei.13231
By:
- Berglund, A.;
- Cleemann, L.;
- Oftedal, B. E.;
- Holm, K.;
- Husebye, E. S.;
- Gravholt, C. H.
Publication type:
Article
A predominant Th1 polarization is present in synovial fluid of end‐stage osteoarthritic knee joints: analysis of peripheral blood, synovial fluid and synovial membrane.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. 395, doi. 10.1111/cei.13230
By:
- Rosshirt, N.;
- Hagmann, S.;
- Tripel, E.;
- Gotterbarm, T.;
- Kirsch, J.;
- Zeifang, F.;
- Lorenz, H.‐M.;
- Tretter, T.;
- Moradi, B.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2019, v. 195, n. 3, p. N.PAG, doi. 10.1111/cei.13170
Publication type:
Article

Works matching IS 00099104 AND DT 2019 AND VI 195 AND IP 3

Immunotherapies based on PD‐1/PD‐L1 pathway inhibitors in ovarian cancer treatment.

Secretory immunoglobulin A induces human lung fibroblasts to produce inflammatory cytokines and undergo activation.

Contribution of FoxP3<sup>+</sup> Tfr cells to overall human blood CXCR5<sup>+</sup> T cells.

FoxP3<sup>+</sup>CXCR5<sup>+</sup>CD4<sup>+</sup> T cell frequencies are increased in peripheral blood of patients with primary Sjögren's syndrome.

Behçet's syndrome as a tool to dissect the mechanisms of thrombo‐inflammation: clinical and pathogenetic aspects.

The immunopathogenesis of fibrosis in systemic sclerosis.

Colonization of preterm gnotobiotic piglets with probiotic Lactobacillus rhamnosus GG and its interference with Salmonella Typhimurium.

Autoantibodies to killer cell immunoglobulin‐like receptor 3DL1 in patients with systemic lupus erythematosus.

CCR6 defines a subset of activated memory T cells of Th17 potential in immune thrombocytopenia.

Monocytes show immunoregulatory capacity on CD4<sup>+</sup> T cells in a human in‐vitro model of extracorporeal photopheresis.

21‐hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.

A predominant Th1 polarization is present in synovial fluid of end‐stage osteoarthritic knee joints: analysis of peripheral blood, synovial fluid and synovial membrane.

Issue Information.